Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY07Dec '07 | FY04Dec '04 | FY03Dec '03 | FY02Dec '02 | FY01Dec '01 |
|---|---|---|---|---|---|
| Revenue | — | $9.41B | $7.21B | $5.47B | — |
| Gross Profit | $0.11B | — | — | — | — |
| Operating Income | — | $1.27B | $0.94B | — | $0.99B |
| Net Income | — | — | $0.65B | — | $0.52B |
| EPS (Diluted) | — | — | $3.24 | $2.79 | — |
| Metric | FY07Dec '07 | FY04Dec '04 | FY03Dec '03 | FY02Dec '02 | FY01Dec '01 |
|---|---|---|---|---|---|
| Total Assets | $30.09B | — | $22.01B | $7.19B | $15.16B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | — | $4.87B | $3.89B | $2.83B | $2.69B |
| Cash & Equivalents | — | $0.42B | $0.43B | — | — |
| Total Debt | — | — | — | — | — |
| Metric | FY07Dec '07 | FY04Dec '04 | FY03Dec '03 | FY02Dec '02 | FY01Dec '01 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.24B | $0.95B | $1.12B | $1.37B | — |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY07Dec '07 | FY04Dec '04 | FY03Dec '03 | FY02Dec '02 | FY01Dec '01 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | 13.5% | 13.0% | — | — |
| Net Margin | — | — | 9.0% | — | — |
| Return on Equity | — | — | 16.7% | — | 19.2% |
| Return on Assets | — | — | 2.9% | — | 3.4% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling SEMPRA — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on SRE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on SRE and publish the result to your public profile.
Ask about SEMPRA
Continue in Workspace — cited answers on SRE, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-K/Aamend | 0000086521-12-000014 | Dec 31, 2011 | Mar 28, 2012 | Mar 29, 2012 00:33 UTC | EDGAR |
| 10-K/Aamend | 0000086521-11-000019 | Dec 31, 2010 | Mar 31, 2011 | Mar 31, 2011 01:22 UTC | EDGAR |
| 10-Q | 0000086521-09-000026 | Mar 31, 2009 | May 5, 2009 | May 5, 2009 22:34 UTC | EDGAR |
| 10-K | 0000086521-09-000010 | Dec 31, 2008 | Feb 24, 2009 | Feb 25, 2009 03:16 UTC | EDGAR |
| 10-Q | 0000086521-08-000064 | Sep 30, 2008 | Nov 10, 2008 | Nov 11, 2008 01:32 UTC | EDGAR |
| 10-Q | 0000086521-08-000043 | Jun 30, 2008 | Aug 7, 2008 | Aug 7, 2008 23:14 UTC | EDGAR |
| 10-Q | 0000086521-08-000031 | Mar 31, 2008 | May 2, 2008 | May 2, 2008 22:49 UTC | EDGAR |
| 10-K | 0000086521-08-000015 | Dec 31, 2007 | Feb 26, 2008 | Feb 27, 2008 02:46 UTC | EDGAR |
| 10-Q | 0000086521-07-000072 | Sep 30, 2007 | Nov 1, 2007 | Nov 1, 2007 23:04 UTC | EDGAR |
| 10-Q | 0000086521-07-000054 | Jun 30, 2007 | Aug 2, 2007 | Aug 3, 2007 00:07 UTC | EDGAR |
| 10-Q | 0000086521-07-000032 | Mar 31, 2007 | May 2, 2007 | May 2, 2007 22:42 UTC | EDGAR |
| 10-K | 0000086521-07-000014 | Dec 31, 2006 | Feb 23, 2007 | Feb 23, 2007 04:07 UTC | EDGAR |
Direct links to SEC EDGAR. SRE has additional filings available on the SEC site.
6 numbers SEMPRA later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2017
Major restatementwas$15M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2018
Major restatementwas$810M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2018
Major restatementwas$1B
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2017
Major restatementwas$1.6B
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2018
Major restatementwas$427M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2017
Major restatementwas$1.6B
Revised down in a 10-K.
SRE is not the only one.
See every restatement we've found across the market — or get an alert the next time SRE revises a number.
Restatements are detected by comparing every vintage of a fact across all of SEMPRA's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows SRE's most significant revisions, and a figure absent from it has not been certified as unrevised.
